Oncotelic Therapeutics (OTCQB: OTLC) announced that Chief Business Officer Saran Saund will deliver the opening keynote on the second day of the 22nd Drug Discovery Strategic Summit on Oct. 22, 2026, at 9 a.m. Pacific Time in Millbrae, California. The presentation will explore partition and aggregation as an organizing principle for AI-enabled drug discovery, emphasizing how complex research questions can be divided into focused investigations and findings combined to develop testable hypotheses.
Saund will discuss the company’s proprietary PDAOAI platform, which indexes approximately 29 million PubMed abstracts, along with its international intellectual property strategy, planned expansion into genetic discovery and Fastbot/Membot technology designed to make AI-powered research accessible to individual investigators. The keynote comes as drug developers increasingly seek ways to harness artificial intelligence to accelerate discovery while managing the complexity of biomedical data.
The implications of the announcement extend beyond a single conference appearance. By detailing a framework that breaks down complex research problems into manageable components, Oncotelic is positioning itself in the growing field of AI-assisted drug discovery. The PDAOAI platform’s indexing of roughly 29 million PubMed abstracts suggests a substantial knowledge base that could support hypothesis generation and validation. The planned expansion into genetic discovery and the Fastbot/Membot technology could lower barriers for individual researchers, potentially democratizing access to AI-driven tools that have often been confined to larger organizations.
Oncotelic Therapeutics develops oncology and immunotherapy products, with a focus on cancers with substantial unmet needs and rare pediatric indications. The company also develops the PDAOAI platform to support its work in drug discovery and development. The full press release can be viewed at https://nnw.fm/O1lLk, and the latest news and updates relating to OTLC are available in the company’s newsroom at https://nnw.fm/OTLC.
The announcement was distributed through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NNW is one of 75+ brands within the Dynamic Brand Portfolio at IBN, which provides access to wire solutions via InvestorWire, editorial syndication to more than 5,000 outlets, press release enhancement, social media distribution and tailored corporate communications solutions. Terms of use and disclaimers applicable to all content provided by NNW are available at https://www.NetworkNewsWire.com/Disclaimer.
